Suggestions for Radiopharmaceutical Drug Development in Korea Focusing on FDA Exploratory IND Guideline

Young-Hoon RYU; Tae-Hyun CHOI; Young-Hoon RYU; Tae-Hyun CHOI.
Nuclear Medicine and Molecular Imaging ; : 525-529, 2007.
Artículo en Ko | WPRIM | ID: wpr-44660

Documentos relacionados

  1. EFFECTIVE HALF-LIFE, EXCRETION AND RADIATION EXPOSURE OF 177LU-PSMA.
  2. Marshalling the Potential of Auger Electron Radiopharmaceutical Therapy.
  3. High-Efficiency Production of Radiopharmaceuticals via Droplet Radiochemistry: A Review of Recent Progress.
  4. Biokinetic models for radiocaesium and its progeny.
  5. Efficient Discovery of Visible Light-Activated Azoarene Photoswitches with Long Half-Lives Using Active Search.
  6. [Application of automatic injection device based on automatic hemostasis in injection of radiopharmaceutical bolus injection].
  7. Exploring Geometrical, Electronic and Spectroscopic Properties of 2-Nitroimidazole-Based Radiopharmaceuticals via Computational Chemistry Methods.
  8. Relevance of Palladium to Radiopharmaceutical Development Considering Enhanced Coordination Properties of TE1PA.
  9. Phase I study assessing the mass balance, pharmacokinetics, and excretion of [<sup>14</sup>C]-pevonedistat, a NEDD8-activating enzyme inhibitor in patients with advanced solid tumors.
  10. Recent achievements in Tc-99m radiopharmaceutical direct production by medical cyclotrons.